EMA — authorised 24 January 2022
- Marketing authorisation holder: H. LUNDBECK A/S
- Status: approved
🇪🇺 Vyepti in European Union
EMA authorised Vyepti on 24 January 2022
Marketing authorisation
Vyepti in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Vyepti approved in European Union?
Yes. EMA authorised it on 24 January 2022.
Who is the marketing authorisation holder for Vyepti in European Union?
H. LUNDBECK A/S holds the EU marketing authorisation.